Macrophages and Biosensor Function in Vivo
体内巨噬细胞和生物传感器功能
基本信息
- 批准号:8067133
- 负责人:
- 金额:$ 44.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:AmputationBacteriaBiocompatible MaterialsBiosensorBlindnessBlood VesselsCellsComplications of Diabetes MellitusCytokine Network PathwayDataDendritic CellsDevelopmentDiabetes MellitusDiabetic mouseDiseaseFibrosisForeign-Body ReactionFutureGiant CellsGlucoseGoalsHealthHeart DiseasesHumanHypertensionIn VitroInflammationInflammatoryKidney DiseasesKnowledgeLeukocytesLiteratureLocationLongevityMusNervous System TraumaPatientsPharmaceutical PreparationsPlayReactionReagentResearchRoleSiteStrokeSystemTestingTherapeutic InterventionTissuesTransgenic MiceUnited Statesangiogenesisbasecostcytokinedesigneconomic costglucose sensorglycemic controlhuman diseaseimplantationimplanted sensorin vivomacrophagemicroorganismmonocytemouse modelmutantnon-diabeticnovelnovel therapeutic interventionpreventsensortoolvessel regression
项目摘要
DESCRIPTION (provided by applicant): Diabetes is truly a "silent killer", whose human and economic costs to the U.S., and the world is vastly under-appreciated. Major complications of diabetes include heart disease, stroke, high blood pressure, kidney disease, blindness, nervous system damage, and amputations. As such, diabetes represents the fifth-deadliest disease in the United States. In 2007 alone, diabetes was estimated to cost the U.S. $174 billion dollars. The key to preventing or at least minimizing the complications of diabetes is glycemic control. Implantable glucose sensors, including sensor based closed loop systems, hold the greatest promise for preventing the devastating complications and economic costs of diabetes. Unfortunately, the development of long-term implantable glucose sensors has been hampered in large part by bio-fouling of the implanted sensor by the tissue reactions associated with sensor-induced "foreign body reactions", including inflammation, fibrosis and vessel regression. The key role of Monocyte Related Cells (MRCs) including macrophages (MQs), dendritic cells (DCs), and multi-nucleated giant cells (GCs) in controlling inflammation, angiogenesis, fibrosis and vessel regression in "foreign body reactions" is well established in a variety of diseases and implantable biomaterials. Although MRCs are known to be present at sites of sensor implantation, the roles of these cells in controlling sensor function directly (biofouling of sensor) and/or indirectly by controlling tissue, reactions (inflammation, angiogenesis and fibrosis) remain to be dissected. The goal of this research is not only to determine the contribution of MRCs and their products to the in vivo loss of sensor function, but also to develop strategies and tools that can extend glucose sensor lifespan in vivo by targeting macrophages and their products at sites of sensor implantation. PUBLIC HEALTH RELEVANCE: Glucose sensors are considered the greatest hope for long-term glucose management for patients with diabetes. Unfortunately, current implantable glucose sensors last for only a few days before sensor function is lost due in large part to tissue inflammation. Our present proposal is focused on determining the role of macrophages, a key inflammatory cell, in this lost of sensor function in vivo. The results of these studies will likely not only provide a new understanding of the role of macrophages in glucose sensing in vivo, but will likely give new tools to control macrophages in vivo and prolong implantable sensor lifespan in vivo.
描述(由申请人提供):糖尿病确实是一个“沉默的杀手”,其给美国和世界造成的人员和经济损失被大大低估。糖尿病的主要并发症包括心脏病、中风、高血压、肾病、失明、神经系统损伤和截肢。因此,糖尿病是美国第五大致命疾病。仅 2007 年一年,糖尿病就给美国造成了 1740 亿美元的损失。预防或至少减少糖尿病并发症的关键是血糖控制。植入式葡萄糖传感器,包括基于传感器的闭环系统,在预防糖尿病的破坏性并发症和经济成本方面具有最大的前景。不幸的是,长期植入式葡萄糖传感器的发展在很大程度上受到与传感器引起的“异物反应”相关的组织反应(包括炎症、纤维化和血管退化)对植入传感器的生物污染的阻碍。单核细胞相关细胞 (MRC) 包括巨噬细胞 (MQ)、树突状细胞 (DC) 和多核巨细胞 (GC) 在控制“异物反应”中的炎症、血管生成、纤维化和血管退化方面的关键作用已得到充分证实在多种疾病和可植入生物材料中。尽管已知 MRC 存在于传感器植入部位,但这些细胞在直接控制传感器功能(传感器的生物污染)和/或通过控制组织反应(炎症、血管生成和纤维化)间接控制传感器功能方面的作用仍有待深入研究。这项研究的目标不仅是确定 MRC 及其产物对体内传感器功能丧失的贡献,而且还开发策略和工具,通过靶向巨噬细胞及其产物,延长体内葡萄糖传感器的寿命。传感器植入。公众健康相关性:葡萄糖传感器被认为是糖尿病患者长期血糖管理的最大希望。不幸的是,目前的植入式葡萄糖传感器只能持续几天,传感器功能在很大程度上会因组织炎症而丧失。我们目前的建议重点是确定巨噬细胞(一种关键的炎症细胞)在体内传感器功能丧失中的作用。这些研究的结果可能不仅会提供对巨噬细胞在体内葡萄糖传感中的作用的新认识,而且可能会提供新的工具来控制体内巨噬细胞并延长体内植入式传感器的寿命。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DON KREUTZER其他文献
DON KREUTZER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DON KREUTZER', 18)}}的其他基金
A novel inline platform provides an advanced drug delivery device foroptimized diabetes therapy
新型在线平台提供先进的药物输送装置,用于优化糖尿病治疗
- 批准号:
10736126 - 财政年份:2023
- 资助金额:
$ 44.4万 - 项目类别:
Development and Validation of Novel Coatings that Extend Glucose Sensor Accuracy and Lifespan in vivo
开发和验证可延长体内血糖传感器精度和寿命的新型涂层
- 批准号:
9898181 - 财政年份:2019
- 资助金额:
$ 44.4万 - 项目类别:
Use of Stem Cells to Enhance and Extend Continuous Glucose Monitoring in Vivo
使用干细胞增强和扩展体内连续血糖监测
- 批准号:
9671761 - 财政年份:2018
- 资助金额:
$ 44.4万 - 项目类别:
Novel approaches to extending glucose sensor lifespan
延长葡萄糖传感器寿命的新方法
- 批准号:
8010495 - 财政年份:2009
- 资助金额:
$ 44.4万 - 项目类别:
相似国自然基金
基于共价有机框架的噬菌体-光催化协同靶向抗菌策略用于顽固性细菌感染的研究
- 批准号:22378279
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于D-氨基酸改性拉曼探针的细菌耐药性快速检测
- 批准号:22304126
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
转录因子3R-MYB调控MeJA诱导双孢菇采后抗细菌褐斑病的分子机制
- 批准号:32372391
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
捕食性细菌黄色黏球菌识别猎物细胞来源磷脂/长链脂肪酸的分子机制
- 批准号:32370122
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
无偏性细菌鞭毛马达转向调控机制研究
- 批准号:12304251
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Engineering recombinant lubricin to combat orthopedic infection
工程重组润滑素对抗骨科感染
- 批准号:
10355887 - 财政年份:2022
- 资助金额:
$ 44.4万 - 项目类别:
Engineering recombinant lubricin to combat orthopedic infection
工程重组润滑素对抗骨科感染
- 批准号:
10659014 - 财政年份:2022
- 资助金额:
$ 44.4万 - 项目类别:
TABA funding for the Fast Track project "ANTIMICROBIAL DERMAL MATRICES TO PROMOTE INFECTION FREE WOUND CLOSURE IN CUTANEOUS WOUNDS_R44GM133305"
TABA 资助快速通道项目“抗菌真皮基质促进皮肤伤口无感染伤口闭合_R44GM133305”
- 批准号:
10526336 - 财政年份:2019
- 资助金额:
$ 44.4万 - 项目类别:
Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds
抗菌真皮基质促进皮肤伤口无感染伤口闭合
- 批准号:
10001816 - 财政年份:2019
- 资助金额:
$ 44.4万 - 项目类别:
Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds
抗菌真皮基质促进皮肤伤口无感染伤口闭合
- 批准号:
10611752 - 财政年份:2019
- 资助金额:
$ 44.4万 - 项目类别: